Prostate Specific Antigen (PSA) Blood Based Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4170050
- 108 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Prostate Specific Antigen (PSA) Blood Based Biomarker market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Prostate Specific Antigen (PSA) Blood Based Biomarker market segmented into
Screening Biomarker
Diagnosis Biomarker
Based on the end-use, the global Prostate Specific Antigen (PSA) Blood Based Biomarker market classified into
Diagnostics
Drug Discovery
Personalized Medicine
Others
Based on geography, the global Prostate Specific Antigen (PSA) Blood Based Biomarker market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
ProteoMediX
Cleveland Diagnostics
Randox
Roche
GENFIT
Nutech Cancer Biomarkers
OGT (Sysmex Group)
Minomic
Creative Diagnostics
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER INDUSTRY
2.1 Summary about Prostate Specific Antigen (PSA) Blood Based Biomarker Industry
2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Production & Consumption Trends
2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Demand Structure Trends
2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Screening Biomarker
4.2.2 Diagnosis Biomarker
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diagnostics
4.3.2 Drug Discovery
4.3.3 Personalized Medicine
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Screening Biomarker
5.2.2 Diagnosis Biomarker
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diagnostics
5.3.2 Drug Discovery
5.3.3 Personalized Medicine
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Screening Biomarker
6.2.2 Diagnosis Biomarker
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diagnostics
6.3.2 Drug Discovery
6.3.3 Personalized Medicine
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Screening Biomarker
7.2.2 Diagnosis Biomarker
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diagnostics
7.3.2 Drug Discovery
7.3.3 Personalized Medicine
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Screening Biomarker
8.2.2 Diagnosis Biomarker
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diagnostics
8.3.2 Drug Discovery
8.3.3 Personalized Medicine
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Screening Biomarker
9.2.2 Diagnosis Biomarker
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diagnostics
9.3.2 Drug Discovery
9.3.3 Personalized Medicine
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 ProteoMediX
10.1.2 Cleveland Diagnostics
10.1.3 Randox
10.1.4 Roche
10.1.5 GENFIT
10.1.6 Nutech Cancer Biomarkers
10.1.7 OGT (Sysmex Group)
10.1.8 Minomic
10.1.9 Creative Diagnostics
10.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Date of Major Players (2017-2020e)
10.2.1 ProteoMediX
10.2.2 Cleveland Diagnostics
10.2.3 Randox
10.2.4 Roche
10.2.5 GENFIT
10.2.6 Nutech Cancer Biomarkers
10.2.7 OGT (Sysmex Group)
10.2.8 Minomic
10.2.9 Creative Diagnostics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type Overview
2.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type Market Share List
3.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type of Major Players
4.Table Brief Introduction of ProteoMediX
5.Table Brief Introduction of Cleveland Diagnostics
6.Table Brief Introduction of Randox
7.Table Brief Introduction of Roche
8.Table Brief Introduction of GENFIT
9.Table Brief Introduction of Nutech Cancer Biomarkers
10.Table Brief Introduction of OGT (Sysmex Group)
11.Table Brief Introduction of Minomic
12.Table Brief Introduction of Creative Diagnostics
13.Table Products & Services of ProteoMediX
14.Table Products & Services of Cleveland Diagnostics
15.Table Products & Services of Randox
16.Table Products & Services of Roche
17.Table Products & Services of GENFIT
18.Table Products & Services of Nutech Cancer Biomarkers
19.Table Products & Services of OGT (Sysmex Group)
20.Table Products & Services of Minomic
21.Table Products & Services of Creative Diagnostics
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
